Original Research

Published on 21 Nov 2024

Mediation effects of metabolites and sex hormones on the relationship between body mass index and breast cancer: Mendelian randomization analysis and mediation analysis

in Breast Cancer

Yanjiang Yang
Min Chen
Wenwen Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1449956

Case Report

Accepted on 19 Nov 2024

Triple-Negative Ectopic Breast Cancer of the Male Scrotum: A Case Report

in Breast Cancer

Shuzhen Liu
Yuhui Nie
Chen Song
Kun Wu
Mingxin Yu
Xin Shen
Yandong Bian

Frontiers in Oncology

doi 10.3389/fonc.2024.1473881

Review

Accepted on 19 Nov 2024

Unlocking the Epigenetic Code: New Insights into Triple-Negative Breast Cancer (TNBC)

in Breast Cancer

Gayathri N. Silva
Gowthami Mahendran
Ann Dharshika Shangaradas
Ricardo Romero Moreno
Nadeeshika Wickramarachchige Dona
S.H.G. Sumudu Sarasija
Sumeth Perera

Frontiers in Oncology

doi 10.3389/fonc.2024.1499950

Correction

Published on 19 Nov 2024

Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells

in Breast Cancer

Ninni Elise Olafsen
Siddhartha Das
Chiara Gorrini
Jason Matthews

Frontiers in Oncology

doi 10.3389/fonc.2024.1516633

Original Research

Published on 19 Nov 2024

Construction of a risk prediction model for axillary lymph node metastasis in breast cancer based on gray-scale ultrasound and clinical pathological features

in Breast Cancer

Quifang Ouyang
Qiang Chen
Luting Zhang
Qing Lin
Jinxian Yan
Haibin Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1415584

136 views

Original Research

Accepted on 18 Nov 2024

RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer

in Breast Cancer

Charlotte K Kindt
Sidse Ehmsen
Sofie Traynor
Benedetta Policastro
Nikoline Nissen
Mie Kiilerich Jakobsen
Monique F Hundebøl
Lene E Johansen
Martin Bak
Elsa Arbajian

Frontiers in Oncology

doi 10.3389/fonc.2024.1497093

Editorial

Accepted on 18 Nov 2024

Editorial: Women in Breast Cancer Volume III 2023

in Breast Cancer

Francesca Bianchi
Anika Nagelkerke

Frontiers in Oncology

doi 10.3389/fonc.2024.1515282

Case Report

Published on 18 Nov 2024

Case report: Triple-negative breast cancer with low tumour-infiltrating lymphocytes infiltration and good prognosis: a case of Tall Cell Carcinoma with Reversed Polarity and review of the literature

in Breast Cancer

Shuoying Jiao
Junpeng Chen
Jiumei Shen
Ajing Peng
Ruifu Chen
Baoyong Lai
Chunhua Luo
Yingyi Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1455893

124 views

Original Research

Accepted on 15 Nov 2024

Medical history of thyroid cancer does not impair prognosis in non-metastatic breast cancer patients: an analysis study based on SEER database and external cohort

in Breast Cancer

Shuai Li
Xiaosong Chen
Kunwei Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1443467

Original Research

Published on 15 Nov 2024

Breaking barriers: improving mammography screening accessibility and quality of care for breast cancer women with disabilities in Saudi Arabia

in Breast Cancer

Huda I. Almohammed

Frontiers in Oncology

doi 10.3389/fonc.2024.1398061

363 views

Review

Published on 15 Nov 2024

An overview of invasive micropapillary carcinoma of the breast: past, present, and future

in Breast Cancer

Pu Qiu
Qiuxia Cui
Shengchao Huang
Yuanqi Zhang
Haitao Zhang
Hui Luo

Frontiers in Oncology

doi 10.3389/fonc.2024.1435421

147 views

Original Research

Published on 15 Nov 2024

Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells

in Breast Cancer

Keenan L. Flynn
Yan Zheng
Janel Y. Sowers
Nefretiri J. T. Masangya
Kevin D. Houston

Frontiers in Oncology

doi 10.3389/fonc.2024.1452981

266 views

Case Report

Published on 14 Nov 2024

Incidental discovery of invasive lobular carcinoma and anaplastic large cell lymphoma during sentinel lymph node biopsy: a case report

in Breast Cancer

Euitae Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1440126

178 views

Original Research

Accepted on 13 Nov 2024

The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting

in Breast Cancer

Marcin Kubeczko
Anna Polakiewicz-Gilowska
Andrea D'Amico
Olgierd Chrabański
Katarzyna Świderska
Ewa Chmielik
Sławomir Blamek
Daria Handkiewicz-Junak
Michał Jarząb

Frontiers in Oncology

doi 10.3389/fonc.2024.1454844

Review

Published on 13 Nov 2024

Molecular mechanism of bone metastasis in breast cancer

in Breast Cancer

Laijian Sui
Jing Wang
Wen G. Jiang
Xicheng Song
Lin Ye

Frontiers in Oncology

doi 10.3389/fonc.2024.1401113

169 views

Case Report

Accepted on 12 Nov 2024

Case Report: Prolonged Benefit of ESG401, a Trop2 Antibody-Drug Conjugate, in Endocrine-Refractory Hormone Receptor-Positive, HER-2 Negative Metastatic Breast Cancer

in Breast Cancer

Jing Zhao
Fengbo Huang
Xia Xu
Yan Zhang
Xiaoyan Xing
Jian Huang
Fuming Qiu

Frontiers in Oncology

doi 10.3389/fonc.2024.1444431

Navigation group

Articles

Mediation effects of metabolites and sex hormones on the relationship between body mass index and breast cancer: Mendelian randomization analysis and mediation analysis

Triple-Negative Ectopic Breast Cancer of the Male Scrotum: A Case Report

Unlocking the Epigenetic Code: New Insights into Triple-Negative Breast Cancer (TNBC)

Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells

Construction of a risk prediction model for axillary lymph node metastasis in breast cancer based on gray-scale ultrasound and clinical pathological features

RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer

Editorial: Women in Breast Cancer Volume III 2023

Case report: Triple-negative breast cancer with low tumour-infiltrating lymphocytes infiltration and good prognosis: a case of Tall Cell Carcinoma with Reversed Polarity and review of the literature

Medical history of thyroid cancer does not impair prognosis in non-metastatic breast cancer patients: an analysis study based on SEER database and external cohort

Breaking barriers: improving mammography screening accessibility and quality of care for breast cancer women with disabilities in Saudi Arabia

An overview of invasive micropapillary carcinoma of the breast: past, present, and future

Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells

Incidental discovery of invasive lobular carcinoma and anaplastic large cell lymphoma during sentinel lymph node biopsy: a case report

The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting

Molecular mechanism of bone metastasis in breast cancer

Case Report: Prolonged Benefit of ESG401, a Trop2 Antibody-Drug Conjugate, in Endocrine-Refractory Hormone Receptor-Positive, HER-2 Negative Metastatic Breast Cancer